Tech Company Financing Transactions

Swift Biosciences Funding Round

Swift Biosciences, operating out of Ann Arbor, scored $500 thousand in funding from Mercury Fund and private investors.

Transaction Overview

Company Name
Announced On
3/31/2012
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors

Mercury Fund (Dan Watkins)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
674 S. Wagner Rd. 100
Ann Arbor, MI 48103
USA
Email Address
Overview
Swift Biosciences is developing molecular biology reagents for research and diagnostic applications.Our products help users to detect genes and gene products that other products can't. We also help users to analyze their samples faster, at higher volume, and at a lower price-per-sample.
Profile
Swift Biosciences LinkedIn Company Profile
Social Media
Swift Biosciences Company Twitter Account
Company News
Swift Biosciences News
Facebook
Swift Biosciences on Facebook
YouTube
Swift Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Nathan Wood
  Nathan Wood LinkedIn Profile  Nathan Wood Twitter Account  Nathan Wood News  Nathan Wood on Facebook
Chief Financial Officer
James Militello
  James Militello LinkedIn Profile  James Militello Twitter Account  James Militello News  James Militello on Facebook
Chief Scientific Officer
Vladimir Makarov
  Vladimir Makarov LinkedIn Profile  Vladimir Makarov Twitter Account  Vladimir Makarov News  Vladimir Makarov on Facebook
VP - Marketing
Camille Cappello
  Camille Cappello LinkedIn Profile  Camille Cappello Twitter Account  Camille Cappello News  Camille Cappello on Facebook
VP - Product Management
Laurie Kurihara
  Laurie Kurihara LinkedIn Profile  Laurie Kurihara Twitter Account  Laurie Kurihara News  Laurie Kurihara on Facebook
VP - Sales
Haley Fiske
  Haley Fiske LinkedIn Profile  Haley Fiske Twitter Account  Haley Fiske News  Haley Fiske on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2012: Molecular Sensing venture capital transaction
Next: 3/31/2012: Zacharon Pharmaceuticals venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary